comparemela.com

Page 2 - Pharma Major News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pharma Major: Zydus acquires UK based LiqMeds Group

Cipla raises margin guidance for FY24 to 23%

Pharma major has also set aside a substantial capital expenditure budget of Rs 10,000-15,000 crore for the fiscal year

Glenmark Pharma gets ANDA approval for Deferasirox Tablets for Oral Suspension – Central Chronicle – Central India s Premier English Daily

Glenmark Pharma gets ANDA approval for Deferasirox Tablets for Oral Suspension – Central Chronicle – Central India s Premier English Daily
centralchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from centralchronicle.com Daily Mail and Mail on Sunday newspapers.

Seeking clarity, guidance from govt for vaccine import: Cipla

Seeking clarity, guidance from govt for vaccine import: Cipla The statement came after a report said the company is seeking fast-track approvals to expeditiously bring Moderna s single-dose COVID-19 booster vaccine into India. Share Via Email   |  A+A A- An employee works at the reception area of Cipla at its headquarters in Mumbai, India June 17, 2015. | Reuters By PTI NEW DELHI: Pharma major Cipla on Tuesday said it is seeking clarity and guidance from the government on the possible roadmap to import vaccine, while stressing that it has been at the forefront of COVID-19 care. The statement came after a report by PTI on Monday said the company is seeking fast-track approvals to expeditiously bring Moderna s single-dose COVID-19 booster vaccine into India.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.